About this trial
This study aims to investigate whether using a low-sodium substitute salt can help improve outcomes for patients with heart failure. Specifically, it will examine if the low-sodium substitute salt can reduce death rates, hospital readmissions, and emergency visits, as well as improve the quality of life for these patients.
Eligibility criteria
Qualifiers
Aged between 18 and 75 years;
Hospitalized due to heart failure in the past year;
NYHA functional class II-III;
Echocardiographic evidence of LVEF < 40% within the past 6 months;
Disqualifiers
End-stage heart failure;
Hospitalization due to cardiovascular causes within the past month;
Uncorrected hyponatremia (Na < 130 mmol/L);
Dialysis-dependent patients, or eGFR < 20 mL/min/1.73m²;
Trial design
Treatments tested in this trial
- low-sodium substitute salt
Treatment groups
Sponsors and collaborators
Heart Health Research Center
Lead sponsor
Beijing Anzhen Hospital
Collaborator